June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 5.68 billion in 2025 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
July 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 11.65 billion in 2025, with a CAGR of 6.83%.
July 2026
The global next-generation cancer therapeutics market size was evaluated at USD 92.54 billion in 2025 and is predicted to hit around USD 186.65 billion by 2035, growing at a CAGR of 7.27%.
July 2026
The global fallopian tube cancer therapeutics market size is expected to increase from USD 1.93 billion in 2025 to hit around USD 5.41 billion by 2035, growing at a CAGR of 10.86%.
June 2026
The breast cancer diagnostics market size is valued at USD 20.14 billion in 2025 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
June 2026
The global cancer therapeutics and biotherapeutics market size was valued at USD 210.73 billion in 2025 and is expected to hit around USD 475.26 billion by 2035, growing at a CAGR of 8.47%.
June 2026
The colorectal cancer diagnostics market size reached USD 16.9 billion in 2025 and is estimated to hit around USD 38.66 billion by 2035 with a CAGR of 8.63%.
June 2026
The global breast cancer therapeutics market size was valued at USD 33.45 billion in 2025 and is expected to hit around USD 66.72 billion by 2035, at a CAGR of 7.27%.
May 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 19.16 billion in 2025, with a CAGR of 9.25%.
May 2026
The global cancer therapeutics market size was evaluated at USD 212.58 billion in 2025 and is expected to surpass around USD 501.07 billion by 2034 with a CAGR of 8.95%.
March 2026
The global allergy diagnostics and therapeutics market size is expected to hit around USD 75.07 billion by 2035 from USD 38.76 billion in 2025 with a CAGR of 6.83%.
February 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 9.72 billion in 2025, with a CAGR of 6.36%.
February 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.21 billion in 2025 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
February 2026
The global cancer diagnostics market size was exhibited at USD 170 billion in 2025 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
January 2026
The global peptide-based cancer therapeutics market size was evaluated at USD 9.47 billion in 2025 and is predicted to hit around USD 24.85 billion by 2035, growing at a CAGR of 10.13%.
January 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 173.13 billion in 2025, with a CAGR of 7.32%.
December 2025
The global small cell lung cancer therapeutics market size is projected to hit around USD 22.86 billion by 2035 from USD 7.25 billion in 2025 with a CAGR of 12.17%.
December 2025
The global gastric cancer diagnostics market size is evaluated at USD 1.32 billion in 2025 and is predicted to hit around USD 2.72 billion by 2035, growing at a CAGR of 7.51%.
December 2025
The homecare diagnostics & therapeutics market size accounted for USD 269.92 billion in 2025 and is expected to hit USD 577.56 billion by 2035, with a CAGR of 7.90%.
November 2025
The global lung cancer diagnostics market size is estimated at USD 5.35 billion in 2025 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
July 2025
The pet cancer therapeutics market size was estimated at USD 448.03 million in 2023 and is projected to surpass around USD 1,150.70 million by 2034 with a CAGR of 9.89%.
June 2025
The global colorectal cancer therapeutics market size is expected to hit around USD 19.95 billion by 2034 from USD 12.79 billion in 2024 with a CAGR of 4.55%.
February 2025
The lung cancer therapeutics market size is valued at USD 35.37 billion in 2025 and is expected to hit around USD 76.65 billion by 2035, growing at a CAGR of 8.04%.
July 2026
The U.S. oncology molecular diagnostics market size is projected to surge USD 2,740 million by 2035 from USD 880 million in 2025 with a notable CAGR of 12.03%.
July 2025
The global biopsy needle market size is expected to attain around USD 2.82 billion by 2034 from USD 1.39 billion in 2024 with a CAGR of 7.33%.
July 2026
The pain management therapeutics market size accounted for USD 88.19 billion in 2025 and is predicted to hit around USD 127.78 billion by 2035, with a CAGR of 3.78%.
July 2026
The global alkaptonuria therapeutics market size is estimated at USD 16.19 million in 2025 and is expected to hit around USD 32.27 million by 2035, growing at a CAGR of 7.14%.
July 2026
The global digital therapeutics market size was exhibited at USD 9.73 billion in 2025 and is projected to surpass around USD 65.31 billion by 2035, with a remarkable CAGR of 20.97%.
July 2026
The artificial intelligence in diagnostics market size was calculated at USD 1.94 billion in 2025 and is projected to hit around USD 11.82 billion by 2035 with a CAGR of 19.81%.
July 2026
The global point-of-care diagnostics market size is exhibited at USD 64.08 billion in 2025 and is predicted to be worth around USD 85.03 billion by 2035 with a CAGR of 2.87%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com